Compass Therapeutics Stock In The News

CMPX Stock  USD 2.46  0.01  0.40%   
Our overall analysis of Compass Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Compass Therapeutics. The specific impact of Compass Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Compass Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Compass Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Compass Therapeutics Backtesting and Compass Therapeutics Hype Analysis.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Compass Therapeutics Today Top News and Investor Outlook

Yahoo News
12 Best Rising Penny Stocks To Buy
https://finance.yahoo.com/news/12-best-rising-penny-stocks-165636339.html
 Bullish
Macroaxis News: globenewswire.com
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/09/2777240/0/en/Compass-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Compass Therapeutics to Participate in Upcoming Investor Events
https://www.globenewswire.com/news-release/2023/11/07/2775057/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-Investor-Events.html
 Bullish
Yahoo News
3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition
https://finance.yahoo.com/news/3-healthcare-stocks-millionaire-next-120035825.html
 Bullish
Macroaxis News: globenewswire.com
Compass Therapeutics to Participate in Upcoming Investor Events
https://www.globenewswire.com/news-release/2023/08/30/2734246/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-Investor-Events.html
 Neutral
Yahoo News
11 Best Biotech Penny Stocks to Buy Now
https://finance.yahoo.com/news/11-best-biotech-penny-stocks-124446644.html
 Neutral
Macroaxis News: globenewswire.com
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/08/03/2717954/0/en/Compass-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
https://www.globenewswire.com/news-release/2023/06/22/2693312/0/en/Compass-Therapeutics-to-be-Added-to-the-Russell-2000-and-Russell-3000-Indexes.html
 Bullish
Macroaxis News: globenewswire.com
Compass Therapeutics to Participate in Upcoming Investor Events
https://www.globenewswire.com/news-release/2023/06/01/2680515/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-Investor-Events.html
 Neutral
Macroaxis News: globenewswire.com
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/05/04/2661507/0/en/Compass-Therapeutics-Reports-First-Quarter-Financial-Results-and-Provides-Corporate-Update.html
 Neutral

Compass Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Compass and other traded companies coverage with news coverage. We help investors stay connected with Compass headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Compass Stock performance. Please note that trading solely based on the Compass Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Compass Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Compass Therapeutics investors visualize upcoming and past events in order to time the market based on Compass Therapeutics noise-free hype analysis.
Compass Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Compass earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Compass Therapeutics that are available to investors today. That information is available publicly through Compass media outlets and privately through word of mouth or via Compass internal channels. However, regardless of the origin, that massive amount of Compass data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Compass Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compass Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compass Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compass Therapeutics alpha.

Compass Largest EPS Surprises

Earnings surprises can significantly impact Compass Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-03
2023-06-30-0.08-0.09-0.0112 
2025-02-27
2024-12-31-0.0944-0.11-0.015616 
2024-03-21
2023-12-31-0.09-0.11-0.0222 
2021-11-12
2021-09-30-0.12-0.10.0216 
2024-11-12
2024-09-30-0.11-0.080.0327 
2024-05-13
2024-03-31-0.11-0.080.0327 
View All Earnings Estimates

Compass Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Compass Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
12th of March 2025
Compass Therapeutics Projected to Post Earnings on Thursday - Defense World
at news.google.com 
news
5th of March 2025
Short Interest in Compass Therapeutics, Inc. Expands By 28.4
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
28th of February 2025
Compass Therapeutics Inc Reports Annual EPS of -0.36, Revenue of 0.88 Million for 2024
at gurufocus.com 
news
25th of February 2025
Investment Analysts Updated EPS Estimates for February 25th
at thelincolnianonline.com 
Google News at Macroaxis
19th of February 2025
Piper Sandler initiates coverage on Compass Therapeutics with overweight rating - TradingV...
at news.google.com 
Macroaxis News
13th of February 2025
Acquisition by Shin Barry of 250000 shares of Compass Therapeutics at 3.65 subject to Rule...
at MacroaxisInsider 
news
11th of February 2025
How Is Compass Therapeutics Gaining Market Traction
at kalkinemedia.com 
insidermonkey News
4th of February 2025
Why Compass Therapeutics Inc Is Skyrocketing So Far In 2025
at insidermonkey.com 
Yahoo News
31st of January 2025
Compass Therapeutics Stock Skyrockets 108 percent in a Month Heres Why
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Compass Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Compass Therapeutics' short interest history, or implied volatility extrapolated from Compass Therapeutics options trading.

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.